CD4 and type 1 diabetes mellitus: These certainly would have to do with the relevant autoantigenic epitopes, as well as the molecules that the T1D-causing pMHCII complexes interact with such cognate TCRs and CD4 co-stimulatory molecules, and perhaps other molecules in the respective signal transducing pathways.